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Abstract 
The concerted [3+2] ylide-alkene photocyclization proceeds through trans-fused ylide 
intermediates. This reaction has been demonstrated to produce multicyclic heterocycles 
with up to six chiral centers in excellent yields from simple starting materials. This 
reaction can be used to develop novel compounds toward the discovery of new 
pharmacophores. Developments toward an asymmetric variant of this reaction have been 
undertaken.  
  
4 
 
Acknowledgments 
 I would like to thank Professor Dittami for his resources and time, without whom 
this project would not have been possible. I would also like to thank Victor Kiryak for his 
time and knowledge, and for answering all of those questions that come up in a new lab 
space. I would also like to extend my gratitude to Professor McGimpsey and Professor 
Lambert as well as the other members of their research group for the use of materials and 
for their time.  
5 
 
Background 
Amino acids are the monomeric species which make up proteins and enzymes in 
living things. The 20 natural amino acids (AAs) are primarily responsible for the 
structure and function of biological entities. Proteins, made up of polymerized strings of 
the 20 natural AAs, are responsible in the body for an overwhelming variety of enzymatic 
and structural functions. AAs are also involved in innumerable biochemical interactions, 
including metabolism and catabolism, regulation of pathways, and immunostimulation 
and suppression
1
. Because of their close tie to biochemical effects, use of unnatural 
amino acids to prepare synthetic enzymes as well as other peptide drugs has grown
2
. As 
developments in proteomics and genomics 
gain knowledge into the structure and activity 
relationships of enzymes and other peptides, 
there is a drive to create compounds with 
novel structural properties, in the hopes that 
affecting these enzymes will impart 
pharmacological properties. Incorporating 
unnatural AAs in peptide analogues has been 
used to alter conformational flexibility, 
enzymatic stability, and pharmacodynamics 
                                                 
1
 Voet, D., Voet, J. G., & Pratt, C. W. (2006). Fundamentals of biochemistry: life at the molecular level. 
New York: Wiley. 
2
 A. Hasuoka, Y. Nishikimi, Y. Nakayama, K. Kamiyama, M. Nakao, et al; J Antibiot 55 322-336 (2002); 
T.R. Ryder, L.-Y. Hu, M.F. Rafferty, S.M. Lotarski, D.M. Rock, et al.; Drug Des. Discovery 16 317-322 
(2000); A.Y. Jeng, P. Savage, M.E. Beil, W. Bruseo, D. Hoyer, et al; Clin. Sci. 103-Suppl 48, 98-101S 
(2002); A.G. Beck-Sickinger; Methods Mol. Biol. (Totowa, N. J.) 73 61-73 (1997); F.A. Davis, B.-C. 
Chen; Chem. Soc. Rev. 27 13-18 (1998) 
 
Figure 1 - Pharmacologically Active Amino 
Acid Derivatives
4
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and bioavailablity
3,4
. Incorporation of AAs into proteins has also proven to be a valuable 
tool to aid in the study of structure-function activities in biochemistry
5
.   
There are a number of drugs on the market today which incorporate unnatural AA 
components. L-DOPA, shown in Figure 1, used for the treatment of Parkinson’s disease, 
is a derivative of tyrosine, and a direct metabolic precursor to dopamine. Low levels of 
dopamine are characteristic of Parkinson’s disease, causing violent, uncontrollable 
shaking
6
. D-Penicillamine is a metabolite of penicillin, a derivative of the cysteine, and 
has no antibiotic properties. However, it acts as an immunosuppressant and is thus 
utilized as a treatment for rheumatoid arthritis
7
. D-Cycloserine is an antibiotic which is 
typically used as a second-line drug for mycobacterium tuberculosis, if one or more first 
line drugs cannot be used
8
. Unnatural amino acids are also incorporated as components to 
many drugs on the market, including amoxicillin and ampicillin.  
Researchers have also been successful at using the natural mechanisms of the 
cell’s ribosome in order to allow for the use of unnatural amino acids in peptide chains9,5. 
This advancement will allow for the design of synthetic enzymes made up of synthetic 
amino acids which are assembled by the preexisting biological components of bacteria 
(or other organisms). This process allows for the encoding of a synthetic enzyme made 
up of synthetic amino acids into ribonucleic acid sequences (RNAs), a great advance for 
biotechnology.  
                                                 
3
 M. Goodman, H. Shao; Pure Appl. Chem. 68 1303-1308 (1996); G. Lubec, G. A. Rosenthal; Amino 
Acids: Chemistry, Biology, and Medicine; B. V., Leiden, Neth., 1990;  
4
 J. Ma; Chimica Oggi. 65-68 (2003); 
5
 Monahan, S., Lester, H., Dougherty, D.; Chemistry & Biology, 10 573–580 (2003) 
6
 F. Hefti, E. Melamed; Trends in Neurosciences 3, 10 229-231 (1980) 
7
 Walshe JM ; Mov. Disord. 18 (8): 853–9 (2003) 
8
 G.B.M. Clarke, A.J.O’Hea;  Br Med J 1 636-638 (1961) 
9
 Feng Tian, Meng-Lin Tsao, and Peter G. Schultz; J. AM. CHEM. SOC. 126 15962-15963 (2004)  
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There is a clear drive to synthesize unnatural amino acids in the pursuit of 
compounds which exhibit useful biological activity. The synthesis of amino acids 
presents specific difficulties to organic synthesis. Amino acids include mutually reactive 
functional groups, and use of functional groups is required to mask the functionality of 
part of the molecule. Protection steps can often lead to racemization, which leads to 
complications in purification steps. AAs typically exist in a zwitterionic form at neutral 
pH. Amino acids are quite soluble in water but insoluble in many common organic 
solvents. Amino acids are chiral molecules and usually only a single enantiomer is of 
interest, so separation of enantiomers is required for symmetric syntheses. This problem 
creates a need for synthetic reactions which can exhibit stereospecificity to maximize 
yield efficiency. The development of stereospecific reactions to form complex unnatural 
amino acids is clearly of scientific merit.  
Synthesis of chirally specific compounds requires the utilization of reactions 
which exhibit a high degree of stereospecificity. Stereospecific reactions are those which 
yield different stereoisomers depending on the stereochemistry of the reactant. For 
example, the standard SN2 reaction which involves the nucleophilic displacement of a 
leaving group from carbon is stereospecific, resulting in the inversion of stereochemistry.  
Photochemical reactions proceed through predictable transition states and often exhibit a 
high degree of stereospecificity. A huge benefit to photochemical reactions is that the 
consumption of stoichiometric quantities of reagents are not required to transform the 
substrate, only the substrate itself. Photochemistry has been used to generate many 
complex compounds in relatively few steps, from simple starting materials, and could be 
employed with great utility in the synthesis of novel amino acids.  
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The photoinitiated intramolecular ylide-alkene cycloaddition has been used to 
generate multicyclic heterocycles with up to 6 chiral centers by exploiting the use of an 
intramolecular [3+2] cycloaddition to the intermediate ylide.  This reaction, shown in 
Scheme 1, has been demonstrated by many researchers, and much is known about its 
mechanism and use
10,11,12,13,14
. 
 This reaction has been explored as a means to generate complex heterocycles 
from simple starting materials. This reaction is reported to proceed through a trans-fused 
ylide intermediate, shown in Scheme 1. This reaction can be directed based on reaction 
conditions to undergo a hydrogen shift rearrangement or to undergo an intramolecular 
addition reaction to give multicyclic addition products
14
, as shown in Scheme 2.  
                                                 
10
 Dittami, J.P., Ramanathan, H., et al.; Tetrahedron Lett., 30 795 (1989) 
11
 Dittami, J.P., Nie X-Y, et al.; Syn. Commun., 20 (4) 541 (1990) 
12
 Dittami, J.P., Nie X-Y, et al.; Tetrahedron Lett., 3821 (1990) 
13
 Dittami, J.P., Nie X-Y, et al.; J. Org. Chem., 56 5572 (1991) 
14
 Dittami, J.P., Nie X-Y, et al.; J. Org. Chem., 57 1151 (1992) 
Scheme 1 – Mechanism of the photoinitiated [3+2] ylide-alkene cycloaddition 
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Several structural features have been shown to facilitate the [3+2] cycloaddition 
reaction over the hydrogen shift reaction product. Compounds which contain an oxygen 
for the heteroatom (X=O) as opposed to a sulfur, or an electron donating group in the 
aromatic ring show a greater tendency to undergo the [3+2] cycloaddition. Use of a 
naphthalene ring or other multicyclic heterocycle enhances the yield of [3+2] product
13,14
. 
Additionally, the incorporation of an electron withdrawing group conjugated to the 
alkene in the side chain helps promote formation of the [3+2] adducts
14
.  
Scheme 2 –Reaction Pathways 
 
10 
 
 
The rationalization behind the relative reactivity between each compound is 
straightforward, and can be easily expressed in terms of the stability of the ylide 
intermediate. The use of a naphthalene ring, multicyclic heteroaromatic, or an aromatic 
ring with an electron donating substituent such as a methoxy group in the starting 
material play a large role in the formation and stability of the ylide reaction 
intermediate
15
. The ylide formed in the intermediate still retains a degree of aromatic 
character if a multicyclic aromatic is used. Compounds which contain an electron 
donating group in the aromatic ring stabilize the intermediate ylide by donating electron 
density to the ylide intermediate, stabilizing the ylide and prolonging its lifetime.   
Stabilization of the ylide through resonance benefits the reactivity of the 
intermediate species toward formation of the [3+2] cycloaddition adducts. According to 
Frontier Molecular Orbital (FMO) Theory, the cycloaddition involves the Highest 
Occupied Molecular Orbital (HOMO) of the dipole (ylide) which is in an excited state. 
The Lowest Unoccupied Molecular Orbital (LUMO) of the dipolarophile (alkene in the 
                                                 
15
 Schultz, A.G. Acc. Chem. Res. 16 210 (1983) 
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side chain) is at a higher energy than the dipole HOMO, and this energy difference is 
required to undergo the [3+2] cycloaddition. The incorporation of an electron 
withdrawing group, such as the ethyl ester group, in conjugation to the alkene lowers the 
energy of the LUMO of the side chain, and thus lowers the energy required for the 
reaction between the ylide and the alkene. Lowering this energy increases the rate of 
reaction and this is evidenced by the reaction yields
16,17,18
.  
There are many examples in the research to support the use of a nitrogen atom to 
be incorporated in the reaction, which is a requirement for the development of the 
intramolecular [3+2] ylide-alkene cycloaddition toward the synthesis of amino acid 
derivatives
19
,
20
,
21
.  
 
A problem with the synthetic utility of the [3+2] ylide-alkene cycloaddition 
reaction has to do with its potential to create enantiomers. In developing the utility of the 
concerted reaction for the synthesis of amino acid derivatives, efforts toward an 
asymmetric variant of the reaction were taken.  In order to impose asymmetry on the 
reaction sequence, there needs to be some method to restrict or lock the conformation in 
                                                 
16
 Houk, K. N., Sims, J., et al.; J. Am. Chem. Soc. 95 7287 (1973) 
17
 Curran, D.P., Ed., Advances in Cycloaddition I (1988) 
18
 Huisgen, R. Fulka, C. et al.; Bull. Soc. Chim. Beig. 93 (1984) 
19
 Schultz, A.G. Hagmann, W.K.; Chem. Commun. 726 (1976) 
20
 Hagmann, W.K.; Ph.D. Thesis, Cornell University 
21
 Schultz, A.G. Hagmann, W.K.; J. Org. Chem. 43 4231 (1978) 
 
12 
 
an asymmetric way. A common method to control the stereochemical configuration of a 
compound during synthesis is to impose a bulky chiral auxiliary group to achieve 
stereospecificity through steric interactions. In many cases, a ring is used to constrain the 
conformation. For example, in the synthesis of unnatural AAs shown below, a chiral ring 
component was used to maintain asymmetry
22,23,24
.  
 
There is precedent to achieve the six electron heterocyclization using S-proline to 
retain chiral configuration during the cyclization reaction. The S-proline can be removed 
after the cyclization to yield adducts of 98% optical purity
25
. 
                                                 
22
 Hammer, K., Undheim, K. Tetrahedron 53 16 5925-5936 (1997) 
23
 Park, K. Kurth, M. Tetrahedron 58 8629–8659 (2002) 
24
 Xiao, D. et al.; Tetrahedron: Asymmetry, 8 18 3043-3046 (1997) 
25
 Castle, R.; Lectures in Heterocyclic Chemistry 9 (1987) 
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This reaction is reported to proceed via a ylide intermediate, in the same fashion as the 
photoinitiated six electron cyclization. Approaching the idea of asymmetry in terms of 
the concerted cyclization and intramolecular [3+2] addition outlined above would allow 
for the production of complex heterocycles of high optical purity. Incorporation of a 
pendant alkene side chain into the compound above should allow for this reaction to 
proceed. The model compound to test in the concerted six electron heterocyclization and 
ylide-alkene cycloaddition is shown in below. This compound can illustrate the potential 
feasibility of this reaction to achieve high chiral purity from simple starting materials.   
 
 Since compound 1 is not commercially available, a synthesis was devised. 
Retrosynthetic analysis shows the compound could be synthesized from a coupling of a 
pyruvic acid derivative with proline-aniline amide. The pyruvic acid butane derivative 
could be made from the pyruvic acid and 4-bromo-butene, by using the dianion of the 
Scheme 4 – Asymmetric Variant of the Photoinitiated [3+2] ylide-alkene cycloaddition  
 
Scheme 3 – Conformational Restriction of Photoarylation Reaction25 
 
14 
 
dimethyl hydrazone of pyruvic acid
26
. Pyruvic acid and 4-bromobutene are commercially 
available. The proline-aniline amide product could be made through an amide 
condensation of aniline and s-proline, both commercially available.  
 
 
There is ample precedent for these conversions in literature. The coupling of the 
proline-aniline amide 4 with pyruvic acid has been shown
27
, requiring treatment with 
thionyl chloride followed by treatment with triethylamine. The reaction yields the α,β-
unsaturated carbonyl compound. The proline-aniline amide 4 can be obtained by the 
dicyclohexylcarbodiimide coupling of t-BOC protected proline 6 with aniline
28
. The t-
                                                 
26
 Tapia, I. Alcazar, V. The Chemical Society of Japan, 697-700 (1990) 
27
 Roloff, A. et al.; Pure Appl. Chem., 58. 1267 (1986) 
28
 Han, S-Y.; Kim, Y-A.; Tetrahedron, 60,11, 2447-2467 (2004) 
Scheme 5 - Retrosynthetic Analysis 
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BOC protected proline group can be synthesized by the reaction of tBOC anhydride with 
s-proline
29
.  
 
 In summary, there is ample precedent to support the synthesis plan of 1. 
Compound 1 should be easily obtained from s-proline, aniline, and the pyruvic acid 
derivative, which are all structurally simple compounds. Compound 1 is expected to yield 
2 upon irradiation with ultraviolet light in a high degree of enantiomeric purity. 
Compound 2 should then yield the synthetic amino acid 3 in an enantiomerically pure 
form.    
  
  
                                                 
29
 Gleason, J.L, Boeckman, R.K., Org. Syn. Coll. Vol. 10, 12 (2004) 
 
Scheme 6 - Synthesis Plan for Compound 1 
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Results and Discussion 
 The overall goal of this project is to develop the methodology of the 
photoinitiated ylide-alkene [3+2] cycloaddition toward an asymmetric variant of the 
reaction. The synthesis plan, outlined in Scheme 7, should show the efficacy of this 
method to synthesize complex heterocycles of high optical purity. The use of chiral ring 
auxiliaries to control the stereochemistry of substrates is a commonly employed method 
in synthesis. The model compound 1 was selected at the outset of the project which 
would contain an S-proline ring component in order to direct the stereochemistry of the 
ylide-alkene cycloaddition.  
The product of the reaction sequence is a synthetic amino acid derivative of 
proline, which may exhibit many uses either as a potentially biologically active 
compound or as an artificial amino acid for use in artificial protein synthesis.  
The first goal of the project was to synthesize 1. This compound incorporates a phenyl 
vinyl amine as well as an alkene side chain, and contains a conformational restriction 
imposed by the chirality of the ring system. Upon irradiation with ultraviolet light, 1 is 
expected to yield 2 which, upon treatment with acid, should yield the amino acid 
derivative 3
30
. The first step was to synthesize protected S-proline 6 so that it could be 
coupled to aniline with DCC. The choice of the t-butoxycarbonyl (tBOC) group was 
made because of its stability to basic conditions, and its facile cleavage in trifluoroacetic 
acid (TFA)
31
. tBOC anhydride (tBOC2O) is a reagent commonly employed to introduce 
the tBOC group to primary as well as secondary amines.  
                                                 
30
 Castle, R.; Lectures in Heterocyclic Chemistry 9 (1987) 
31
 Gleason, J.L, Boeckman, R.K., Org. Syn. Coll. Vol. 10, 12 (2004) 
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Scheme 7 – Synthesis Plan 
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Treatment of S-proline with aqueous bicarbonate and tBOC anhydride in 1,4-
dioxane yielded tBOC-S-proline (6) in ~60% isolated yield. 
1
HNMR analysis in CDCl3 
showed what appeared to be poor resolution, with broadened and indistinct multiplets. To 
improve resolution, several recrystallizations from 1:3 EtOAc-Hexane were done. The 
spectra did not seem to show any improvement. There was a doublet observed at δ=1.45-
1.51ppm, J=30.25Hz which integrated to 9H corresponding to the t-butyl protons on the 
tBOC protecting group. This was strange, as a singlet was expected for this signal.  
 
Due to the highly asymmetric nature of the molecule, it was hypothesized that 
virtual coupling was the cause of the poor resolution. Virtual coupling is known to occur 
in chiral ring structures, leading to solvent-dependent coupling interactions that can make 
1
HNMR spectra difficult to interpret
32
. These problems often occur with chiral ring 
systems such as glycosides, where prochiral hydrogens appear as broadened signals due 
to virtual coupling interactions
33
. It was hypothesized that protons B-G, as shown in the 
figure, interact through virtual coupling and thus cause complicated multiplicities, 
causing overlap of many of the signals and the apparently low resolution of the spectra. It 
                                                 
32
 Robins, M. MacCoss, M.; J. Am. Chem. Soc.,  99, 14, 4660–4666 (1977) 
33
 Pauli, G.; J. Nat. Prod. 63, 834-838 (2000) 
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was thought that protons B, C, and D overlap in the region of δ=1.8-2.2ppm, proton E in 
the region δ=2.2-2.4, proton F and G at δ=3.3-3.6ppm, and proton H at δ= 4.2-4.4ppm. 
These observations agree with literature results
34
.  
Amide bond rotation has been known to cause splitting of signals
35
. Since amide 
bonds rotate freely, and when the amide adopts a planar conformation and allows for 
resonance interaction between the lone pair of electrons on the amide nitrogen and the 
carbonyl group, there is the possibility for signals to appear as distinct in spectra. If the 
resonance stabilization can slow the rotation of the amide so it is slower than an NMR 
transition, splitting will occur in the protons affected by the rotation. In tBOC-S-proline, 
the 9 t-butyl hydrogens appear as a doublet at δ=1.455ppm and 1.519ppm, with 
J=30.25Hz, a large coupling constant consistent with amide bond rotation interactions
36
.  
 
Since the virtual coupling effects and the amide rotation effects are solvent 
dependent
37,38
, deuterated methanol was employed to test for these effects. When the 
compound was analyzed in d-methanol, a sharpening of the multiplets and a change in 
the coupling constants for the t-butyl protons was observed. As shown in Figure 2, the 
signals observed in the spectrum taken with d-methanol as the solvent were more crisp 
and distinct, evidence of complicated virtual coupling interactions as hypothesized. The 
                                                 
34
 Fu, Y-Q., Li. Z-C.; Tetrahedron: Asymmetry, 17, 3351-3357 (2006) 
35
 Pavia, D. L. (2009). Introduction to spectroscopy. Belmont, CA: Brooks/Cole, Cengage Learning. 
36
 Quintanilla-Licea, R.; Molecules, 7, 662-673 (2002) 
37
 Pauli, G.; J. Nat. Prod. 63, 834-838 (2000) 
38
 Musher, J.I., Corey, E.J., Tetrahedron, 18, 6, 791 (1962) 
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coupling constant for the doublet observed for the t-butyl protons was 18.85Hz, as 
opposed to 30.25Hz in CDCl3. This is evidence of the amide rotation effect. 
 
 Once the concerns with the NMR spectra were clarified, the next step in the 
synthesis was undertaken. This reaction, the coupling of tBOC-S-proline with aniline to 
form compound 5, was attempted using dicyclohexylcarbodiimide (DCC) in THF. 
 
 
Figure 2 - HNMR spectra of nBOC-proline in CDCl3 (top) and d-methanol (bottom) 
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This reaction gave a considerably low yield (~16%) and it was hypothesized that the age 
of the DCC reagent combined with the wetness of the THF contributed to the loss of 
product. In order to compensate for the possible wetness of solvents, a more stable 
reagent was chosen. 1-Ethyl-3-(3-dimethyllaminopropyl)carbodiimide hydrochloride 
(EDC-HCl) was available on-hand, and is known to be stable in an aqueous environment 
and used in the coupling of amines to carboxylic acids, and was selected for use in the 
synthesis of 5
39
. Treatment of aniline with triethylamine in dichloromethane yielded 
~80% of compound 5. 
 The 
1
HNMR spectra of compound 5 in CDCl3 contained many aspects which 
affected the interpretation of the tBOC-S-proline (6). For example, the broadening and 
interference of multiplets was observed for the compound, appearing to be low 
resolution. It was hypothesized that the signals would show a difference in d-methanol, 
just like 6, and indeed, these effects were observed. The spectra show a solvent 
dependent change in the multiplicity pattern, indicating virtual coupling is present. There 
is also a singlet observed for the t-butyl protons in the CDCl3 spectrum whereas a doublet 
of doublets was observed for the d-methanol spectrum. This can be rationalized in terms 
of the amide bond rotation frequency which is also solvent dependent.  
                                                 
39
 Sathapornvagana, S., Vilaiva, T.; Tetrahedron, 63, 10253-10259 (2007) 
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 Following the coupling reaction, it was necessary that the tBOC protecting group 
be removed. The standard procedure for this transformation is treatment with a 1:1 
mixture of trifluoroacetic acid and methylene chloride
39
. The product of this reaction, 
compound 4, showed a much more defined and crisp NMR spectrum than the tBOC-
protected compound.  
 The last step in synthesizing the target compound 1 was to couple compound 4 
with the pyruvic acid derivative 7. Unfortunately, compound 7 is not readily available, so 
a synthesis was devised. The most direct route to this compound is by allowing the 
dimethylhydrazone of pyruvic acid with 4-bromobutene
40
. Unfortunately, 
dimethylhydrazine was not readily available, and the synthesis of pyruvic acid derivative 
7 was not achieved. Upon the synthesis of 7, the synthesis of 1 should be easily carried 
out, so an alternate synthesis was devised.  
 Due to the structure of pyruvic acid, the regiospecific addition of the alkene side 
chain was a difficulty which warrants concern. Pyruvic acid has two electrophilic 
carbonyl groups, both susceptible to attack from a nucleophilic reagent. There are also 
two acidic protons which can lend themselves to interactions with reagents. The synthesis 
plan must take these problems into consideration. The synthesis plan is outlined below. 
The synthesis of 3-bromopyruvic acid can be achieved by treatment of pyruvic acid with 
elemental bromine and H2SO4
41
.  In order to achieve the selective alkylation at the 
brominated site of compound 9, the alpha-ketone can be protected as a diethyl acetal by 
treatment with triethylorthoformate and H2SO4
42
. Acetal 10 should react with the 4-
bromobutene Grignard reagent to yield compound 11, which can be subsequently 
                                                 
40
 Tapia, I. Alcazar, V. The Chemical Society of Japan, 697-700 (1990) 
41
 Springson, Chargraff.  J. Biol. Chem., 164, 424 (1946). 
42
 Yan, Y-L., Cohen, S. Org. Lett. 9, 13, 2517 (2007) 
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deprotected by treatment in hot formic acid to yield the required pyruvic acid alkene 7
42
. 
Upon the completion of this leg of the convergent synthesis, the target compound 1 
should be ready at hand. 
 
 The photoreaction of 1 is expected to yield 2 in a high degree of enantiomeric 
purity. This stereospecificity can be rationalized in terms of the conformational restriction 
imposed by the proline ring system, which due to its chiral nature, favors a specific 
stereoisomer depending on the chirality of the proline ring. The ring imposes a U shape 
into the overall molecule, where the alkene side chain can more easily access the outer 
edge of the U than the inner, thus resulting in the predicted specificity. The lowest energy 
conformation was predicted using Hyperchem software, utilizing the Polak-Ribiere 
(conjugate gradient) geometry optimization (ab initio, 6-31G* basis set). The result of 
this model is shown below. 
24 
 
 
 In summary, although the synthesis of 1 was not achieved, it should be readily 
synthesized from proline-aniline amide 4 and pyruvic acid derivative 7. Due to the 
geometric restrictions imposed upon compound 1 by the chiral ring auxiliary, irradiation 
with ultraviolet light is expected to yield 2 in a high degree of enantiomeric purity. 
Compound 2 can then be transformed by treatment with acid to amino acid derivative 3.  
  
Figure 3 - Geometry Optimization of Compound 1 
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Experimental Section 
 
General Methods. Analytical thin-layer chromatography (TLC) was performed on 
precoated glass-backed silica plates (0.25 mm thickness with a 254 nm fluorescent 
indicator). Visualization was performed using a UV lamp (254 nm) and by staining with 
a p-anisaldehyde solution. Infrared spectra (IR) were recorded on a Bruker Vertex 70 
Infrared Spectrometer with a 4 cm
-1
 resolution, scanning from 4000 to 650 cm-1 over 16 
scans. 
1
H NMR spectra were recorded on a Bruker Avance III (500 MHz) NMR 
Spectrometer.  Chemical shifts (δ) are reported in ppm relative to tetramethylsilane 
(TMS) at 0.00. Solvents and reagents were used as purchased from Sigma-Aldrich or 
VWR. 
26 
 
(S)-1-(tert-butoxycarbonyl)pyrrolidine-2-carboxylic acid (6) TSV-I-038 
  
A 200mL round bottom flask was charged with 1.1008g solid s-proline and 4.2114g 
NaHCO3. 50mL water was added and stirred with a magnetic stirbar. The solution was 
chilled to 0ºC in an ice-bath. A solution of 2.3310g (1.1 equivalents) in 30mL 1,4-
dioxane was added by the pipette-full Throughout addition, solution became more and 
more cloudy. After about 15 minutes, a white precipitate appeared in the mixture. TLC 
analysis after 100 minutes was taken, the white precipitate was made soluble in MeOH 
with a few drops of 1M NaOH. Analysis showed consumption of starting materials. The 
flask was removed from ice and allowed to warm to room temperature. Aqueous solution 
was extracted twice with 25mL EtOAc. The extract was backextracted twice with 10mL 
0.1M NaOH. Aqueous layers recombined. The solution was acidified to pH 1 with 2M 
HCl. Extracted aqueous solution with 30mL EtOAc. The organic extracts were combined 
and washed with 20mL water, which was back extracted with EtOAc. The organic layers 
were combined and dried over MgSO4. The solvent was stripped via rotovap, yielding 
1.5486g of clear oil which crystallized upon standing to clear white, needle shaped 
crystals (74% yield). Product purified by several recrystallizations from 1:3 
EtOAc:Hexane. 
1
HNMR (CDCl3 500MHz) δ 1.45-1.55 (d, 9H, J=30.25Hz), 1.91-2.10 
(m, 3H), 2.29-2.40 (m, 1H), 3.37-3.58 (m, 2H), 4.28-4.40 (m, 1H), 7.29 (s, 1H 
exchanged). IR 3070, 3020, 2400, 1750, 1640, 1450, 1200, 900cm
-1
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(S)-tert-butyl 2-(phenylcarbamoyl)pyrrolidine-1-carboxylate (5) TSV-I-039a 
 
515.8mg Aniline was added to a round bottom flask. A solution of 1.126g 
dicyclohexylcarbodiimide (DCC) in 30mL THF was added to the flask. 626.2mg t-BOC 
s-proline was added in small spoonfuls. The color became more yellow, the reaction 
mixture was heterogeneous. Reaction mixture was left stirring overnight. The mixture 
had become opaque and milky overnight, TLC (Silica, mobile: 5%MeOH in DCM) 
showed product spot at Rf=0.7. Solvent was stripped from reaction mixture via rotovap, 
and the residue was dissolved in dichloromethane (DCM). Added 10mL AcOH to 
neutralize reactants, at which point mixture became clear and transparent instantly. 
Basified to about pH 10 at which point a white precipitate appeared which stayed with 
the organic layer. The white urea precipitate was filtered and washed with DCM. DCM 
solution dried in MgSO4, and then stripped of solvent via rotovap yielding 245.3mg of a 
yellow solid (24% yield). 
1
HNMR (CDCl3 500MHz) δ 1.52 (s, 9H), 1.92-2.20 (m, 3H), 
2.31-2.45 (m, 1H), 3.37-3.65 (m, 2H), 4.22-4.56 (m, 1H), 7.05-7.65 (m, 5H) 
28 
 
(S)-tert-butyl 2-(phenylcarbamoyl)pyrrolidine-1-carboxylate (5) TSV-I-039b-d 
 
150mg aniline was combined with 10mL DCM and 150mg triethylamine. 313mg tBoc-S-
Proline was added after several minutes with magnetic stirring. 307mg 1-Ethyl-3-(3-
dimethyllaminopropyl)carbodiimide hydrochloride (EDC-HCl) was added. The reaction 
mixture was left stirring overnight. TLC (silica, mobile: 1:! Hexane:EtOAc) showed a 
spot overlapping aniline spot at Rf=0.45. Reaction mixture was washed with water and 
then dried with MgSO4. The solvent was stripped, yielding 350mg of yellow oil which 
crystallized upon standing (80% yield). The solid was purified by recrystallization from 
2% v/v EtOH in EtOAc. 
1
HNMR (CDCl3 500MHz) δ 1.52 (s, 9H), 1.92-2.20 (m, 3H), 
2.31-2.45 (m, 1H), 3.37-3.65 (m, 2H), 4.22-4.56 (m, 1H), 7.05-7.65 (m, 5H). IR 3350, 
2990, 2420, 1640, 1600, 1580, 1560, 1430, 1210, 1090, 900cm
-1
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(S)-N-phenylpyrrolidine-2-carboxamide (4) TSV-I-040 
To a solution of 100mg proline-aniline amide (5) in 10mL dichloromethane was added 
10mL of a 1:1 solution of trifluoroacetic acid in dichloromethane. The mixture was 
stirred in an ice-bath for 2 hours. The product was washed with 10% NaOH solution and 
stripped of solvent yielding 4 as the trifluoroacetic acid salt in nearly quantitative yield. 
1
HNMR (CD3OD, 500MHz) δ 1.04 (m, 1H), 1.25 (m, 1H), 1.51 (m, 1H), 1.92-2.10 (m, 
3H), 3.44 (m, 1H), 7.05-7.65 (m, 5H) 
  
30 
 
Appendix: Spectral Data 
n-tBOC-S-proline HNMR in d-chloroform (TSV-I-038d)  
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n-tBOC-S-proline HNMR in d-methanol (TSV-I-038e.a) 
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n-tBOC-S-proline HNMR in d-methanol multiplet expansion (TSV-I-
038e.a) 
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n-tBOC-S-proline, TOCSY in d-methanol (TSV-I-038f) 
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n-tBOC-S-proline, IR spectrum (neat) 
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 (S)-tert-butyl 2-(phenylcarbamoyl)pyrrolidine-1-carboxylate, HNMR 
spectrum in d-chloroform (TSV-I-039b) 
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(S)-tert-butyl 2-(phenylcarbamoyl)pyrrolidine-1-carboxylate, HNMR 
spectrum in d-methanol (TSV-I-039d) 
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(S)-tert-butyl 2-(phenylcarbamoyl)pyrrolidine-1-carboxylate, d-
methanol expansions (TSV-I-039d) 
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(S)-tert-butyl 2-(phenylcarbamoyl)pyrrolidine-1-carboxylate, IR (neat) 
 
